S'abonner

CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-? - 06/08/18

Doi : 10.1016/j.jaci.2018.02.026 
Otavio Cabral-Marques, PhD a, b, , Tabata Takahashi França, MSc a, , Ashraf Al-Sbiei, PhD c, Lena Friederike Schimke, MD a, b, Taj Ali Khan, PhD a, d, Claudia Feriotti, PhD a, Tania Alves da Costa, PhD a, Osvaldo Reis Junior, PhD e, Cristina Worm Weber, MD f, Janaíra Fernandes Ferreira, MD g, Fabiola Scancetti Tavares, MD h, Claudia Valente, MD h, Regina Sumiko Watanabe Di Gesu, MD i, Asif Iqbal, PhD j, Gabriela Riemekasten, MD b, Gustavo Pessini Amarante-Mendes, PhD k, José Alexandre Marzagão Barbuto, PhD a, l, Beatriz Tavares Costa-Carvalho, MD, PhD m, Paulo Vitor Soeiro Pereira, PhD a, n, Maria J. Fernandez-Cabezudo, PhD o, Vera Lucia Garcia Calich, PhD a, Luigi D. Notarangelo, MD p, Troy R. Torgerson, MD, PhD q, Basel K. al-Ramadi, PhD c, Hans D. Ochs, MD q, Antonio Condino-Neto, MD, PhD a,
a Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil 
j Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil 
k Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil 
l Cell and Molecular Therapy Center, NETCEM, University of São Paulo, São Paulo, Brazil 
b Department of Rheumatology, University Lübeck, Lübeck, Germany 
c Department of Medical Microbiology & Immunology, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates 
o Department of Biochemistry, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates 
d Department of Microbiology, Kohat University of Science and Technology, Kohat, Pakistan 
e Central Laboratory of High Performance Technologies (LaCTAD), State University of Campinas, Campinas, Brazil 
f Pediatric Allergy & Immunology Clinic, Caxias do Sul, Brazil 
g Albert Sabin Hospital, Fortaleza, Brazil 
h Pediatric Immunology Clinic, Unit of Pediatrics, Hospital de Base do Distrito Federal, Asa Sul, Brazil 
i Division of Allergy and Immunology, Department of Pediatrics, Conceicão Children Hospital, Porto Alegre, Brazil 
m Division of Allergy-Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil 
n Department of Pathology, Federal University of Maranhao, São Luis, Brazil 
p Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md 
q Department of Pediatrics, University of Washington School of Medicine, and Seattle Children's Research Institute, Seattle, Wash 

Corresponding author: Antonio Condino-Neto, MD, PhD, Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, 1730 Lineu Prestes Ave, São Paulo 05508-000, Brazil.Department of ImmunologyInstitute of Biomedical SciencesUniversity of São Paulo1730 Lineu Prestes AveSão Paulo05508-000Brazil
Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Monday 06 August 2018
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Background

Patients with X-linked hyper-IgM syndrome caused by CD40 ligand (CD40L) deficiency often present with episodic, cyclic, or chronic neutropenia, suggesting abnormal neutrophil development in the absence of CD40L-CD40 interaction. However, even when not neutropenic and despite immunoglobulin replacement therapy, CD40L-deficient patients are susceptible to life-threatening infections caused by opportunistic pathogens, suggesting impaired phagocyte function and the need for novel therapeutic approaches.

Objectives

We sought to analyze whether peripheral neutrophils from CD40L-deficient patients display functional defects and to explore the in vitro effects of recombinant human IFN-γ (rhIFN-γ) on neutrophil function.

Methods

We investigated the microbicidal activity, respiratory burst, and transcriptome profile of neutrophils from CD40L-deficient patients. In addition, we evaluated whether the lack of CD40L in mice also affects neutrophil function.

Results

Neutrophils from CD40L-deficient patients exhibited defective respiratory burst and microbicidal activity, which were improved in vitro by rhIFN-γ but not soluble CD40L. Moreover, neutrophils from patients showed reduced CD16 protein expression and a dysregulated transcriptome suggestive of impaired differentiation. Similar to CD40L-deficient patients, CD40L knockout mice were found to have impaired neutrophil responses. In parallel, we demonstrated that soluble CD40L induces the promyelocytic cell line HL-60 to proliferate and mature by regulating the expression of genes of the same Gene Ontology categories (eg, cell differentiation) when compared with those dysregulated in peripheral blood neutrophils from CD40L-deficient patients.

Conclusion

Our data suggest a nonredundant role of CD40L-CD40 interaction in neutrophil development and function that could be improved in vitro by rhIFN-γ, indicating a potential novel therapeutic application for this cytokine.

Le texte complet de cet article est disponible en PDF.

Key words : Neutrophils, CD40 ligand, cell development, IFN-γ

Abbreviations used : APC, CD40L, CD62L, CFU, CGD, DEG, DMSO, FITC, fMLP, G-CSF, GPI, MFI, NET, PE, PEC, PMA, Q-VD-OPh, rhIFN-γ, RNAseq, ROS, sCD40L, TLR


Plan


 Supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP; grant 2012/50515-4 to O.C.-M. and grant 2012/51745-3 and 2016/22158-3 to A.C.-N.), the Jeffrey Modell Foundation (to A.C.-N.), and PENSI Institute and Ministério da Saúde do Brasil (PRONAS/PDC 2015 and 25000.077928/2015-06 to A.C.-N.). The animal studies were supported by a UAEU Program for Advanced Research grant (no. 31M193) from the Office of Research and Sponsored Projects, UAE University (to B.K.a.-R.).
 Disclosure of potential conflict of interest: T. R. Torgerson has consultant arrangements with Shire Pharmaceuticals, CSL Behring, UCB Pharmaceuticals, and ADMA Biologics and has received grants from the National Institutes of Health. The rest of the authors declare that they have no relevant conflicts of interest.


© 2018  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.